Yue Hou
Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Lanzhou University Second Hospital(CN)Lanzhou University(CN)Air Force Medical University(CN)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Pregnancy and preeclampsia studies, Click Chemistry and Applications
Most-Cited Works
- → Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients(2019)47 cited
- → Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia(2023)35 cited
- → An Updated Safety and Efficacy Results of Phase 1 Study of HQP1351, a Novel 3rd Generation of BCR-ABL Tyrosine Kinase Inhibitor (TKI), in Patients with TKI Resistant Chronic Myeloid Leukemia(2019)27 cited
- → Novel BCR-ABL1 Tyrosine Kinase Inhibitor (TKI) HQP1351 (Olverembatinib) Is Efficacious and Well Tolerated in Patients with T315I-Mutated Chronic Myeloid Leukemia (CML): Results of Pivotal (Phase II) Trials(2020)26 cited
- → WTAP dysregulation‐mediated HMGN3‐m6A modification inhibited trophoblast invasion in early‐onset preeclampsia(2022)24 cited
- → Circadian clock gene Clock is involved in the pathogenesis of preeclampsia through hypoxia